The Silent Spread: Australia’s Battle with H5N1 and the Global Pandemic Threat
As the Southern Hemisphere moves through the seasonal shifts of the year, health authorities are not only looking at the...
science
Restoring the Drive: Ariadne Bio Launches to Tackle Parkinson’s-Associated Apathy with Novel Serotonin Agonist
The landscape of neuropsychiatric drug development is notoriously difficult to navigate, characterized by high failure rates and a tendency to...
The Dual-Origin Brain: How a Biological "Discovery" Rewrites the History of Human Development
For generations, the scientific community has operated under a singular, intuitive assumption: the human brain is a unified organ, derived...
The Arc of Healing: Decoding the Past, Present, and Future of Sickle Cell Disease
For over a century, sickle cell disease (SCD) has occupied a paradoxical space in medicine: it is simultaneously the most...
Revolutionizing Bioprocessing: The Shift Toward Model-Free Real-Time Analysis
In the high-stakes world of biopharmaceutical manufacturing, the ability to monitor process streams with precision and speed is not merely...
Securing the Upstream: Why Raw Material Strategy is the New Frontier in Bioprocessing
As the global biopharmaceutical landscape shifts toward more sophisticated therapeutic modalities—ranging from complex monoclonal antibodies to next-generation viral vector vaccines—the...
Bridging the Gap: GBI Biomanufacturing Unveils SmartScale™ to Revolutionize Early-Stage Clinical Development
At the 2026 BioProcess International (BPI) East conference, CDMO GBI Biomanufacturing has officially unveiled its new "SmartScale™ GMP Solutions" platform....
Beyond Weight Loss: Eli Lilly’s Brenipatide Targets the Brain to Tackle Addiction and Mental Health
In a bold strategic pivot that underscores the pharmaceutical industry's growing fascination with incretin-based therapies, Eli Lilly and Company has...
Streamlining Bioprocessing: Asahi Kasei Bioprocess Unveils the VANTIJ® SU-VFC Benchtop at BPI East
BOSTON — As the biopharmaceutical industry accelerates the development of complex modalities such as gene therapies, the pressure to optimize...
A New Frontier in Neurodegeneration: Time-Restricted Eating Shows Promise for Huntington’s Disease
For decades, the medical community has sought a breakthrough in the treatment of Huntington’s disease (HD), a devastating, inherited neurological...
Scaling the Frontier of Human-Relevant Models: Molecular Devices and STEMCELL Technologies Unveil Automated Organoid Workflow
In a landmark development for the biotechnology and pharmaceutical research sectors, Molecular Devices and STEMCELL Technologies have announced the successful...
Unlocking the Cellular Secrets of Diabetic Kidney Disease: New Insights from Organoid Models
Diabetic kidney disease (DKD), a devastating complication affecting approximately 40% of individuals living with diabetes, has long been viewed through...
